Management of primary idiopathic hyperphosphatasemia with calcitonin: a case report.
We describe a patient with primary idiopathic hyperphosphatasemia, a rare hereditary disease caused by a primary enzymatic disorder. The clinical, radiological, histological and biochemical features of the disease and their response to treatment with Calcitonin are described. We recommend Calcitonin for this rare disease in specialist units. It leads to improvement in many markers and better function.
Roth
A J
AJ
Orthopädische Universitätsklinik am Rudolf-Elle-Krankenhaus Eisenberg, Eisenberg/Thüringen, Germany.
Abendroth
K
K
Seidel
J
J
Neubert
H
H
Venbrocks
R
R
D000469:Alkaline Phosphatase / Q000097:blood*; D002116:Calcitonin / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008661:Metabolism, Inborn Errors / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D002116:Calcitonin; D000469:Alkaline Phosphatase